These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Mammaglobin expression in primary, metastatic, and occult breast cancer. Watson MA; Dintzis S; Darrow CM; Voss LE; DiPersio J; Jensen R; Fleming TP Cancer Res; 1999 Jul; 59(13):3028-31. PubMed ID: 10397237 [TBL] [Abstract][Full Text] [Related]
9. [Lymph node metastasis of a "squamous cell carcinoma" as a manifestation of occult breast cancer]. Ronay G; Zimmermann HD; Tulusan AH Pathologe; 1988 Sep; 9(5):309-12. PubMed ID: 2845387 [No Abstract] [Full Text] [Related]
10. Axillary lymph node metastases from unknown primary: A French multicentre study. Ouldamer L; Cayrol M; Vital M; Fièvre C; Druelles M; Arbion F; Body G; Lévêque J; Fritel X Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():103-107. PubMed ID: 29518639 [TBL] [Abstract][Full Text] [Related]
11. Endometrial cancer patients have a significant risk of harboring isolated tumor cells in histologically negative lymph nodes. Amezcua CA; MacDonald HR; Lum CA; Yi W; Muderspach LI; Roman LD; Felix JC Int J Gynecol Cancer; 2006; 16(3):1336-41. PubMed ID: 16803526 [TBL] [Abstract][Full Text] [Related]
12. CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence. Zhao Y; Pan Z; Namburi S; Pattison A; Posner A; Balachander S; Paisie CA; Reddi HV; Rueter J; Gill AJ; Fox S; Raghav KPS; Flynn WF; Tothill RW; Li S; Karuturi RKM; George J EBioMedicine; 2020 Nov; 61():103030. PubMed ID: 33039710 [TBL] [Abstract][Full Text] [Related]
13. Cancers of unknown primary origin (CUP) are characterized by chromosomal instability (CIN) compared to metastasis of know origin. Vikeså J; Møller AK; Kaczkowski B; Borup R; Winther O; Henao R; Krogh A; Perell K; Jensen F; Daugaard G; Nielsen FC BMC Cancer; 2015 Mar; 15():151. PubMed ID: 25885340 [TBL] [Abstract][Full Text] [Related]
14. Occult breast cancer may originate from ectopic breast tissue present in axillary lymph nodes. Terada M; Adachi Y; Sawaki M; Hattori M; Yoshimura A; Naomi G; Kotani H; Iwase M; Kataoka A; Onishi S; Sugino K; Mori M; Horisawa N; Sasaki E; Yatabe Y; Iwata H Breast Cancer Res Treat; 2018 Nov; 172(1):1-7. PubMed ID: 30030707 [TBL] [Abstract][Full Text] [Related]
16. Lymph node metastasis of primary endometrial cancers: Associated proteins revealed by MALDI imaging. Mittal P; Klingler-Hoffmann M; Arentz G; Winderbaum L; Lokman NA; Zhang C; Anderson L; Scurry J; Leung Y; Stewart CJ; Carter J; Kaur G; Oehler MK; Hoffmann P Proteomics; 2016 Jun; 16(11-12):1793-801. PubMed ID: 27061135 [TBL] [Abstract][Full Text] [Related]
17. Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Koscielny S; Tubiana M; Lê MG; Valleron AJ; Mouriesse H; Contesso G; Sarrazin D Br J Cancer; 1984 Jun; 49(6):709-15. PubMed ID: 6733019 [TBL] [Abstract][Full Text] [Related]
18. Histologic characteristics of breast cancers with occult lymph node metastases detected by keratin 19 mRNA reverse transcriptase-polymerase chain reaction. Noguchi S; Aihara T; Motomura K; Inaji H; Imaoka S; Koyama H Cancer; 1996 Sep; 78(6):1235-40. PubMed ID: 8826945 [TBL] [Abstract][Full Text] [Related]
20. Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: a systematic literature review. Pentheroudakis G; Greco FA; Pavlidis N Cancer Treat Rev; 2009 May; 35(3):221-7. PubMed ID: 19046817 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]